|
1
|
Harbeck N and Gnant M: Breast cancer.
Lancet. 389:1134–1150. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Razzaghi H, Quesnel-Crooks S, Sherman R,
Joseph R, Kohler B, Andall-Brereton G, Ivey MA, Edwards BK, Mery L,
Gawryszewski V and Saraiya M: Leading causes of cancer
mortality-Caribbean Region, 2003–2013. Morb Mortal Wkly Rep.
65:1395–1400. 2016. View Article : Google Scholar
|
|
4
|
Lejen T, Pene TD, Rosé SD and Trifaró JM:
The role of different Scinderin domains in the control of F-actin
cytoskeleton during exocytosis. Ann N Y Acad Sci. 971:248–250.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen XM, Guo JM, Chen P, Mao LG, Feng WY,
Le DH and Li KQ: Suppression of scinderin modulates
epithelialmesenchymal transition markers in highly metastatic
gastric cancer cell line SGC7901. Mol Med Rep. 10:2327–2333. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Del Castillo Rodriguez A, Lemaire S,
Tchakarov L, Jeyapragasan M, Doucet JP, Vitale ML and Trifaró JM:
Chromaffin cell scinderin, a novel calcium-dependent actin
filament-severing protein. EMBO J. 9:43–52. 1990.PubMed/NCBI
|
|
7
|
Lueck A, Brown D and Kwiatkowski DJ: The
actin-binding proteins adseverin and gelsolin are both highly
expressed but differentially localized in kidney and intestine. J
Cell Sci. 111:3633–3643. 1998.PubMed/NCBI
|
|
8
|
Tchakarov L, Vitale ML, Jeyapragasan M,
Del Castillo Rodriguez A and Trifaró JM: Expression of scinderin,
an actin filament-severing protein, in different tissues. FEBS
Lett. 268:209–212. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang D, Sun SQ, Yu YH, Wu WZ, Yang SL and
Tan JM: Suppression of SCIN inhibits human prostate cancer cell
proliferation and induces G0/G1 phase arrest. Int J Oncol.
44:161–166. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu H, Shi D, Liu T, Yu Z and Zhou C:
Lentivirus-mediated silencing of SCIN inhibits proliferation of
human lung carcinoma cells. Gene. 554:32–39. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zunino R, Li Q, Rosé SD, Romero-Benítez
MM, Lejen T, Brandan NC and Trifaró JM: Expression of scinderin in
megakaryoblastic leukemia cells induces differentiation,
maturation, and apoptosis with release of plateletlike particles
and inhibits proliferation and tumorigenesis. Blood. 98:2210–2219.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu JJ, Liu JY, Chen J, Wu YX, Yan P, Ji
CD, Wang YX, Xiang DF, Zhang X, Zhang P, et al: Scinderin promotes
the invasion and metastasis of gastric cancer cells and predicts
the outcome of patients. Cancer Lett. 376:110–117. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Coratti A, Fernandes E, Lombardi A, Di
Marino M, Annecchiarico M, Felicioni L and Giulianotti PC:
Robot-assisted surgery for gastric carcinoma: Five years follow-up
and beyond: A single western center experience and long-term
oncological outcomes. Eur J Surg Oncol. 41:1106–1113. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin H, Huang JF, Qiu JR, Zhang HL, Tang
XJ, Li H, Wang CJ, Wang ZC, Feng ZQ and Zhu J: Significantly
upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of
invasive ductal breast cancer. Exp Mol Pathol. 94:73–78. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi H, Chen S, Jin H, Xu C, Dong G, Zhao
Q, Wang W, Zhang H, Lin W, Zhang J, et al: Downregulation of MSP58
inhibits growth of human colorectal cancer cells via regulation of
the cyclin D1-cyclin-dependent kinase 4-p21 pathway. Cancer Sci.
100:1585–1590. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Camp RL, Dolled-Filhart M and Rimm DL:
X-tile: A new bio-informatics tool for biomarker assessment and
outcome-based cut-point optimization. Clin Cancer Res.
10:7252–7259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheang MC, Chia SK, Voduc D, Gao D, Leung
S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, et al: Ki67
index, HER2 status, and prognosis of patients with luminal B breast
cancer. J Natl Cancer Inst. 101:736–750. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta (CT)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shankavaram UT, Reinhold WC, Nishizuka S,
Major S, Morita D, Chary KK, Reimers MA, Scherf U, Kahn A, Dolginow
D, et al: Transcript and protein expression profiles of the NCI-60
cancer cell panel: An integromic microarray study. Mol Cancer Ther.
6:820–832. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van Diest PJ, van der Wall E and Baak JP:
Prognostic value of proliferation in invasive breast cancer: A
review. J Clin Pathol. 57:675–681. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim K, Son MY, Jung CR, Kim DS and Cho HS:
EHMT2 is a metastasis regulator in breast cancer. Biochem Biophys
Res Commun. 496:758–762. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song L, Liu D, Zhao Y, He J, Kang H, Dai
Z, Wang X, Zhang S, Zan Y and Xue X: Sinomenine reduces growth and
metastasis of breast cancer cells and improves the survival of
tumor-bearing mice through suppressing the SHh pathway. Biomed
Pharmacother. 98:687–693. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gao Y, Li F, Zhou H, Yang Y, Wu R, Chen Y,
Li W, Li Y, Xu X, Ke C and Pei Z: Down-regulation of MRPS23
inhibits rat breast cancer proliferation and metastasis.
Oncotarget. 8:71772–71781. 2017.PubMed/NCBI
|
|
24
|
Hall A: The cytoskeleton and cancer.
Cancer Metastasis Rev. 28:5–14. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kas SM, de Ruiter JR, Schipper K,
Annunziato S, Schut E, Klarenbeek S, Drenth AP, van der Burg E,
Klijn C, Ten Hoeve JJ, et al: Insertional mutagenesis identifies
drivers of a novel oncogenic pathway in invasive lobular breast
carcinoma. Nat Genet. 49:1219–1230. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mercado-Matos J, Clark JL, Piper AJ,
Janusis J and Shaw LM: Differential involvement of the microtubule
cytoskeleton in insulin receptor substrate 1 (IRS-1) and IRS-2
signaling to AKT determines the response to microtubule disruption
in breast carcinoma cells. J Biol Chem. 292:7806–7816. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kumar N, Hati S, Munshi P, Sen S, Sehrawat
S and Singh S: A novel spiroindoline targets cell cycle and
migration via modulation of microtubule cytoskeleton. Mol Cell
Biochem. 429:11–21. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chumnarnsilpa S, Lee WL, Nag S, Kannan B,
Larsson M, Burtnick LD and Robinson RC: The crystal structure of
the C-terminus of adseverin reveals the actin-binding interface.
Proc Natl Acad Sci USA. 106:13719–13724. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
King KL and Cidlowski JA: Cell cycle
regulation and apoptosis. Annu Rev Physiol. 60:601–617. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jordan VC: The new biology of
estrogen-induced apoptosis applied to treat and prevent breast
cancer. Endocr Relat Cancer. 22:R1–R31. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Carew JS, Espitia CM, Zhao W, Kelly KR,
Coffey M, Freeman JW and Nawrocki ST: Reolysin is a novel
reovirus-based agent that induces endoplasmic reticular
stress-mediated apoptosis in pancreatic cancer. Cell Death Dis.
4:e7282013. View Article : Google Scholar : PubMed/NCBI
|
